We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ELDN market cap is 190.72M. The company's latest EPS is USD -0.6698 and P/E is -4.81.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.34M | -10.87M | -14.5M | -20.51M | -24.7M |
| Net Income | -9.63M | -10.3M | -58.24M | 76.97M | -48.54M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.47M | -36.87M | -88.43M | -43M | -70.58M |
| Net Income | -22.81M | -34.51M | -87.97M | -40.33M | -40.11M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 89.07M | 80.82M | 120.48M | 114.58M | 177.41M |
| Total Liabilities | 5.65M | 6M | 128.98M | 38.52M | 59.27M |
| Total Equity | 83.42M | 74.82M | -8.5M | 76.06M | 118.14M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 197.19M | 170.55M | 92.79M | 89.07M | 177.41M |
| Total Liabilities | 6.59M | 6.55M | 8.61M | 5.65M | 59.27M |
| Total Equity | 190.6M | 164M | 84.18M | 83.42M | 118.14M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -39.53M | -8.74M | -16.52M | -28.28M | -47.27M |
| Investing | -45.29M | 9.78M | -10.13M | -22.93M | -70.31M |
| Financing | 33.02M | 1,000 | 48.07M | 53.36M | 133.52M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.21M | -28.91M | -28.42M | -39.53M | -47.27M |
| Investing | 11.04M | N/A | N/A | -45.29M | -70.31M |
| Financing | 109.58M | -449k | N/A | 33.02M | 133.52M |
| Market Cap | 190.72M |
| Price to Earnings Ratio | -4.81 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.38 |
| Price to Book Ratio | 1.63 |
| Dividend Yield | - |
| Shares Outstanding | 59.88M |
| Average Volume (1 week) | 188.74k |
| Average Volume (1 Month) | 225.44k |
| 52 Week Change | 53.86% |
| 52 Week High | 5.54 |
| 52 Week Low | 2.00 |
| Spread (Intraday) | 0.02 (0.63%) |
| Company Name | Eledon Pharmaceuticals Inc |
| Address |
8 the green dover, delaware 19901 |
| Website | https://www.eledon.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
